FDA 510(k)
FDA class 1
Substantially Equivalent
🇬🇧 United Kingdom
COZART EIA OPIATES ORAL FLUID KIT
K Number: K024339
·
Decision Apr 7, 2003
Classifications
1
FEI Numbers
1
Registration Numbers
1
Same Product Code
0
Applicant Total
6
Review Days
101
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- COZART EIA OPIATES ORAL FLUID KIT
- K Number
- K024339
- Device Class
- FDA class 1
- Clearance Type
- Traditional
- Regulation Number
- 862.3240
- Medical Specialty
- Clinical Toxicology
- Decision
- Substantially Equivalent
- Statement or Summary
- Statement
- Applicant
- Cozart Bioscience , Ltd.
- Date Received
- December 27, 2002
- Decision Date
- April 7, 2003
- Product Code
- DIG
- Advisory Committee
- Clinical Toxicology
- Review Advisory Committee
- TX
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| DIG | Cholinesterase Test Paper | FDA class 1 | Clinical Toxicology |
Other Clearances by Cozart Bioscience , Ltd.
| K Number | Device Name | ||
|---|---|---|---|
| K033743 | COZART EIA AMPHETAMINES ORAL FLUID MICROPLATE KIT | Jun 3, 2004 | Substantially Equivalent |
| K021944 | COZART EIA COTININE URINE KIT | May 14, 2003 | Substantially Equivalent |
| K030234 | COZART EIA COCAINE ORAL FLIUD KIT | Apr 28, 2003 | Substantially Equivalent |
| K020920 | COZART RAPISCAN ORAL FLUID DRUG TEST - OPIATE/METHADONE | Nov 5, 2002 | Substantially Equivalent |
| K011131 | METHADONE MICROPLATE EIA URINE APPLICATION | Jul 31, 2001 | Substantially Equivalent |